Skip to main content
. 2020 Dec 11;17(24):9285. doi: 10.3390/ijerph17249285

Table 2.

Economic costs of patients with 3GCREC and 3GCSEC for potential confounding variables.

Confounding Variables Hospital Cost ($) 3GCSEC 3GCREC Difference p Value
Median 95% CI Median 95% CI Median 95% CI
Excluding LOS before culture Total hospital cost 3867 3558 4185 5233 4737 5638 1366 1179 1453 <0.000
Antibiotic cost 126 99 143 278 246 311 152 146 168 <0.000
Medication cost 1418 1286 1563 2045 1863 2279 627 577 715 <0.000
Diagnostic cost 873 844 914 955 901 992 81 57 79 <0.000
Treatment cost 778 719 858 1142 1043 1250 363 324 393 <0.000
Material cost 187 160 225 321 289 368 134 129 143 <0.000
Other costs 8 8 9 9 8 10 1 0 1 0.003
Including LOS before culture Total hospital cost 4057 3791 4435 5197 4733 5662 1140 942 1227 <0.000
Antibiotic cost 132 108 150 260 235 297 127 127 147 <0.000
Medication cost 1522 1385 1689 2037 1840 2281 515 456 592 <0.000
Diagnostic cost 886 848 916 953 909 1002 67 61 85 <0.000
Treatment cost 841 773 934 1111 1018 712 271 245 296 <0.000
Material cost 199 172 238 306 273 352 107 101 114 <0.000
Other costs 8 7 9 9 8 10 1 1 1 0.0213

3GCREC: third-generation cephalosporin-resistant Escherichia coli; 3GCSEC: third-generation cephalosporin-susceptible E. coli; LOS: length of stay; CI: certainty interval.